Krishna Nayini
Interventional Cardiology · Longview, TXNPI 1326158890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $685 and has fallen 88.3% since, to $80 in 2024. That places this record below the midpoint for interventional cardiology clinicians in TX, where the typical reported total is $9,094.
Across 149 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$513
- Medtronic$415
- Johnson & Johnson$382
- Edwards Lifesciences$274
- Irhythm Technologies, Inc.$145
- Gilead$87
- plus $558 from 12 others
What the payments were for
- Food & beverage$2,376100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 38 | $513 |
| Medtronic(2 entities) | 27 | $415 |
| Johnson & Johnson | 27 | $382 |
| Edwards Lifesciences | 12 | $274 |
| Irhythm Technologies, Inc. | 7 | $145 |
| Gilead | 6 | $87 |
| Philips North America LLC | 2 | $83 |
| Merck | 5 | $82 |
| Pfizer | 5 | $79 |
| Amgen | 4 | $55 |
| E.r. Squibb & Sons, L.L.C. | 4 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $32 |
| Chiesi USA, Inc. | 2 | $30 |
| Abbott | 2 | $27 |
| Biotronik Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$2,376 in reported general payments places this provider in the 10th percentile of 686 interventional cardiology providers in Texas.
Other interventional cardiology in Longview
- Juan GranadaHouston$4.1M
- Vamsi KrishnaKyle$2M
- Jeffrey CarrTyler$1.9M
- John IsaacHouston$1.8M
- Robert ChiltonSan Antonio$1.3M
- Sameh SayfoPlano$1M
- Srinivasa PotluriPlano$781K
- Karim Al-AziziPlano$734K
- Robert StolerDallas$587K
- Peter MonteleoneKyle$461K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.